
Sign up to save your podcasts
Or
Is it time to rethink perioperative immunotherapy in resectable gastric and gastroesophageal junction (GEJ) cancers? See the latest data and expert takeaways. Credit available for this activity expires: 7/18/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002710?ecd=bdc_podcast_libsyn_mscpedu
4
77 ratings
Is it time to rethink perioperative immunotherapy in resectable gastric and gastroesophageal junction (GEJ) cancers? See the latest data and expert takeaways. Credit available for this activity expires: 7/18/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002710?ecd=bdc_podcast_libsyn_mscpedu
136 Listeners
13 Listeners
323 Listeners
102 Listeners
884 Listeners
503 Listeners
16 Listeners
289 Listeners
3,333 Listeners
87 Listeners
1,140 Listeners
190 Listeners
514 Listeners
367 Listeners
60 Listeners
25 Listeners
430 Listeners
372 Listeners